Correlation Between Novolog Pharm and Compugen

Can any of the company-specific risk be diversified away by investing in both Novolog Pharm and Compugen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novolog Pharm and Compugen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novolog Pharm Up 1966 and Compugen, you can compare the effects of market volatilities on Novolog Pharm and Compugen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novolog Pharm with a short position of Compugen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novolog Pharm and Compugen.

Diversification Opportunities for Novolog Pharm and Compugen

0.0

Correlation Coefficient

Novolog Pharm  Compugen

Pay attention - limited upside

The 24 months correlation between Novolog and Compugen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Novolog Pharm Up 1966 and Compugen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compugen and Novolog Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novolog Pharm Up 1966 are associated (or correlated) with Compugen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compugen has no effect on the direction of Novolog Pharm i.e., Novolog Pharm and Compugen go up and down completely randomly.

Pair Corralation between Novolog Pharm and Compugen

If you would invest  90,010  in Compugen on March 5, 2024 and sell it today you would lose (2,210) from holding Compugen or give up 2.46% of portfolio value over 90 days.

Time Period	24 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Novolog Pharm Up 1966  vs.  Compugen

Novolog Pharm Up

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novolog Pharm Up 1966 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Novolog Pharm is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Compugen

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Compugen are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Compugen sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Novolog Pharm and Compugen

The main advantage of trading using opposite Novolog Pharm and Compugen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novolog Pharm position performs unexpectedly, Compugen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will offset losses from the drop in Compugen's long position.

The idea behind Novolog Pharm Up 1966 and Compugen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.